MoneyWorks4Me

Ajanta Pharma informs about updates

12 Sep 2022 Evaluate

Ajanta Pharma has informed that its formulation facility at Dahej was inspected by US FDA from 5th September 2022 to 9th September 2022. At the end of the inspection, Form 483 was issued to them with 2 procedural observations. The company is in the process of responding to the same within the stipulated time prescribed by US FDA.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..